Pursue Wealth Partners’s Gilead Sciences GILD Stock Holding History

Pursue Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,248	Closed	-$592K	–	103
2026 Q1	$592K	Hold	4,248	–	–	0.35%	55
2025 Q4	$521K	Hold	4,248	–	–	0.25%	61
2025 Q3	$472K	Hold	4,248	–	–	0.26%	63
2025 Q2	$471K	Hold	4,248	–	–	0.27%	65
2025 Q1	$476K	Hold	4,248	–	–	0.29%	66
2024 Q4	$392K	Hold	4,248	–	–	0.22%	64
2024 Q3	$356K	Hold	4,248	–	–	0.19%	73
2024 Q2	$291K	Hold	4,248	–	–	0.16%	77
2024 Q1	$311K	Hold	4,248	–	–	0.18%	73
2023 Q4	$344K	Sell	4,248 -124	-3%	-$9.65K	0.22%	67
2023 Q3	$328K	Hold	4,372	–	–	0.23%	71
2023 Q2	$337K	Hold	4,372	–	–	0.21%	75
2023 Q1	$363K	Hold	4,372	–	–	0.25%	72
2022 Q4	$375K	Hold	4,372	–	–	0.29%	72
2022 Q3	$270K	Hold	4,372	–	–	0.19%	84
2022 Q2	$270K	Hold	4,372	–	–	0.17%	92
2022 Q1	$267K	Hold	4,372	–	–	0.11%	115
2021 Q4	$317K	Buy	+4,372	New	+$301K	0.12%	110

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pursue Wealth Partners's GILD Position: Q2 2026 in Review

Pursue Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 4,248 shares — an estimated $592K sold.

Pursue Wealth Partners first reported a position in GILD in Q4 2021 and held it in 18 quarters. The position peaked at $592K in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Pursue Wealth Partners reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Pursue Wealth Partners sold 4,248 Gilead Sciences shares in Q2 2026, an estimated $592K.
Pursue Wealth Partners first reported a position in Gilead Sciences in Q4 2021 and held it in 18 quarters.
Pursue Wealth Partners's Gilead Sciences position peaked at $592K in Q1 2026.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pursue Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.